NAMS - NewAmsterdam Pharma Co N.V.
31.18
0.775 2.486%
Share volume: 883,667
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$30.40
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-06-2024 | 02-26-2025 | 05-08-2025 | 11-05-2025 | 02-18-2026 | |
| Cash flow financing | 198.180 M | 4.658 M | 58.000 K | 456.611 M | 6.519 M | 5.892 M | 13.684 M | |
| Other financing cash flows | 198.695 M | 4.658 M | 58.000 K | 456.636 M | 8.105 M | 5.892 M | 13.684 M | |
| Cash flow | 143.193 M | -49.530 M | -12.519 M | 356.951 M | -27.094 M | -24.371 M | -48.332 M | |
| Net income | -93.767 M | -39.007 M | -16.647 M | -92.177 M | -39.527 M | -72.005 M | -74.923 M | |
| Depreciation | 15.000 K | 19.000 K | 28.000 K | 51.000 K | 52.000 K | 64.000 K | 59.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -385.000 K | -209.000 K | -75.000 K | -62.179 M | 2.855 M | 2.506 M | -21.141 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 385.000 K | 209.000 K | 75.000 K | 3.000 K | 16.000 K | 42.000 K | 100.000 K | |
| Cash Change | 143.193 M | -49.530 M | -12.519 M | 356.951 M | -27.094 M | -24.371 M | -48.332 M |